FeedsFarm.com > FDA Safety Labeling Changes: Mifeprex, Flovent Diskus, Enbrel

Source:

Medscape Womens Health Headlines

Language:

English

Tag/Category:

pharmacist

Domain:

www.medscape.com

More feeds from medscape.com:

• Medscape Business of Medicine Headlines
• Medscape FamilyMedicine Headlines
• Medscape Infectious Diseases Headlines
• Medscape Medical News Headlines
• Medscape Molecular Medicine Headlines
• Medscape Nephrology Headlines
• Medscape Pharmacist Headlines
• Medscape PublicHealth Headlines
• Medscape Rheumatology Headlines
• Medscape Technology and Medicine Headlines

Search medscape.com:

FDA Safety Labeling Changes: Mifeprex, Flovent Diskus, Enbrel

26th Oct 2005, 23:15 GMT

The FDA has approved revisions to the safety labeling for mifepristone tablets (Mifeprex), fluticasone propionate inhalation powder (Flovent Diskus), and etanercept subcutaneous injection (Enbrel). (CME) Medscape Medical News Yael Waknine

Latest news from Medscape Womens Health Headlines:

• STD-Prevention Counseling Practices and Human Papillomavirus Opinions Among Clinicians with Adolescent Patients --- United States, 2004